the changing approaches to polycythemia vera: a clinical perspective
Published 4 months ago • 359 plays • Length 2:05Download video MP4
Download video MP3
Similar videos
-
1:30
the patient perspective of polycythemia vera and second-line treatment options
-
6:31
the current treatment landscape for polycythemia vera
-
3:07
the current treatment algorithm for polycythemia vera
-
2:46
an update on emerging therapies for the treatment of polycythemia vera
-
6:38
novel approaches for mpns
-
10:56
identifying and communicating your polycythemia vera (pv) symptoms
-
29:13
essential thrombocythemia: pathogenesis and management
-
6:01
common signs and symptoms of polycythemia vera
-
3:59
pv: outcomes, unmet needs, and therapeutic strategies
-
1:52
cytoreductive therapy for patients with pv
-
2:16
ropeginterferon vs standard therapy for polycythemia vera
-
5:50
machine-learning to predict hydroxyurea failure & thromboembolic events in polycythemia vera
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
0:54
study design for persist-2 and other upcoming trials of pacritinib
-
3:15
updates on ropeginterferon in pv
-
3:36
mpns as discrete subtypes
-
0:31
change the way you see polycythemia vera ‐ takeactionpv
-
4:59
behind the mystery, polycythemia vera
-
1:05
the prognostic and potentially therapeutic value of liquid biopsy in multiple myeloma
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp
-
2:36
highlights of the texas mpn workshop 2020
-
22:10
designing novel polymeric systems with enhanced mucoadhesive and mucus-penetrating properties